Skip to main content
. 2022 Feb 15;47(5):932–941. doi: 10.1111/ced.15094

Table 4.

Prevalence of dermoscopy criteria for patients with invasive vs. in situ tiny melanomas and univariable logistic regression for dermoscopy features predicting invasiveness in patients with tiny melanomas. a

Invasive (n = 38) In situ (n = 47) OR 95% CI P of 95% CI
Menzies' method, n (%)
Asymmetry of pattern 28 (73.7) 36 (76.6) 0.86 0.32–2.30 0.76
≥ 5 colours 0 (0.0) 0 (0.0) NA NA NA
Blue–whitish veil 0 (0.0) 1 (2.1) 0.40 b 0.02–10.17 0.57
Brown dots 23 (60.5) 33 (70.2) 0.65 0.26–1.60 0.35
Pseudopods 2 (5.3) 1 (2.1) 2.56 0.22–29.31 0.45
Radial streaming 6 (15.8) 5 (10.6) 1.58 0.44–5.42 0.48
Scar‐like depigmentation 2 (5.3) 3 (6.4) 0.82 0.13–5.14 0.83
Peripheral black dots and globules 5 (13.2) 10 (21.3) 0.56 0.17–1.81 0.33
Multiple blue–grey dots (peppering) 0 (0.0) 2 (4.3) 0.26 b 0.02–5.51 0.51
Broadened network 11 (28.9) 16 (34.0) 0.79 0.31–1.99 0.62
7‐point checklist, n (%)
Atypical pigment network 16 (42.1) 22 (46.8) 0.83 0.35–1.96 0.67
Blue–whitish veil 0 (0.0) 1 (2.1) 0.43 b 0.02–11.03 0.61
Atypical vascular pattern 8 (21.1) 0 (0.0) 26.48 b 1.47–475.50 < 0.01
Irregular dots and globules 26 (68.4) 39 (83.0) 0.44 0.16–1.24 0.12
Irregular streaks 6 (15.9) 6 (12.8) 1.28 0.38–4.35 0.69
Regression structures 11 (28.9) 7 (14.9) 2.32 0.80–6.76 0.12
Irregular pigmentation 17 (44.7) 14 (29.8) 1.91 0.78–4.67 0.16
3‐point checklist, n (%)
Asymmetry in structure or colour 30 (78.9) 36 (76.6) 1.15 0.41–3.22 0.80
Atypical network 17 (44.7) 23 (48.9) 0.85 0.36–1.99 0.70
Blue–white structures 12 (31.6) 9 (19.1) 1.95 0.72–5.29 0.19
Revised pattern analysis (chaos and clues), n (%)
Asymmetry of pattern 28 (73.7) 36 (76.6) 0.75 0.28–1.99 0.56
Asymmetry of colour 20 (52.6) 24 (51.1) 1.07 0.45–2.51 0.89
Grey or blue structures 15 (39.5) 7 (14.9) 3.73 1.33–10.47 0.01
Thick lines 10 (26.3) 18 (38.3) 0.58 0.23–1.46 0.25
White lines 4 (10.5) 0 (0.0) 12.39 b 0.65–237.80 0.04
Eccentric structureless areas 5 (13.2) 12 (25.5) 0.44 0.14–1.39 0.16
Peripheral black dots or clods 5 (13.2) 10 (21.3) 0.56 0.17–1.81 0.33
Radial lines or pseudopods 6 (15.8) 6 (12.8) 1.28 0.38–4.35 0.69
Polymorphous vessels 5 (13.2) 0 (0.0) 15.60 b 0.83–291.70 0.02
Polygons 0 (0.0) 1 (2.1) 0.40 b 0.02–10.17 0.57
Atypical vessels, n (%)
Dotted 6 (15.9) 0 (0.0) 19.00 b 1.03–349.10 < 0.01
Linear 6 (15.9) 0 (0.0) 19.00 b 1.03–349.10 < 0.01
Coiled or glomerular 2 (5.3) 0 (0.0) 6.51 b 0.31–139.71 0.18
Serpentine 2 (5.3) 0 (0.0) 6.51 b 0.31–139.71 0.18
Corkscrew 1 (2.6) 0 (0.0) 3.8 b 0.15–95.98 0.39
Global pattern, n (%)
Homogeneous 2 (5.3) 3 (6.5) 0.80 0.13–5.03 0.81
Multicomponent 4 (10.5) 4 (8.5) 1.27 0.30–5.43 0.75
Starburst 6 (15.9) 6 (12.8) 1.28 0.38–4.35 0.69
Reticular 3 (7.9) 10 (21.3) 0.32 0.08–1.25 0.10
Globular 3 (7.9) 6 (12.8) 0.59 0.14–2.52 0.47
Unspecific 20 (52.6) 18 (38.3) 1.79 0.75–4.26 0.19
Additional features, n (%)
Chrysalis 4 (10.5) 0 (0.0) 12.39 b 0.65–237.80 0.04
Shiny white blotches 2 (5.3) 0 (0.0) 6.51 b 0.31–139.71 0.18
Rosettes 1 (2.6) 0 (0.0) 3.8 b 0.15–95.98 0.39
Negative network 2 (5.3) 1 (2.1) 2.56 0.22–29.31 0.45
Milky‐red areas 3 (7.9) 1 (2.1) 3.94 0.39–39.54 0.24
Milky‐red globules 0 (0.0) 1 (2.1) 0.40 b 0.02–10.17 0.57

NA, not applicable.

a

One patient with a tiny melanoma was excluded from the analysis due to low quality image.

b

Haldane–Anscombe correction was used for cases with zero values.